ArticleBiotechnology journal2026
Engineering Modification for the Efficient Synthesis of β-ionone by Yarrowia lipolytica.
Article in Biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
β-Ionone, prized for its characteristic violet aroma and woody undertones, has emerged as a valuable ingredient in the fragrance industry. Beyond its aromatic qualities, growing interest in its diverse biological activities has positioned it as a compound of relevance in the biopharmaceutical field. As production strategies shift from traditional chemical synthesis toward more sustainable biological routes, this study explores the engineered biosynthesis of β-ionone in Yarrowia lipolytica. Through systematic combinatorial metabolic engineering, a strain capable of accumulating 743 mg/L of β-carotene was constructed. Heterologous expression of the petunia-derived carotenoid cleavage dioxygenase gene PhCCD1 enabled efficient conversion of β-carotene to β-ionone, yielding 137 mg/L in shake-flask cultures. Subsequent integration of the isoprene alcohol metabolic pathway further enhanced precursor supply, boosting β-ionone production to 236.7 mg/L in shake flasks. In a 5 L bioreactor, optimization of the culture medium and feeding strategy led to a final titer of 624.7 mg/L. Collectively, these results establish a promising and replicable strategy for developing microbial cell factories capable of efficient β-ionone synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.